Relenza
Product Images NDC 54868-4377

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Relenza (NDC 54868-4377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 5 mg Package Label (4377)

Label for RELENZA 5MG Diskhaler, distributed by Physicians Total Care, Inc. The label includes the NDC number 54868-4377-0, indicates a package count of 20, and shows a lot number and expiration date. A barcode with numeric code 43770200000 is visible at the bottom.*

FDA Label Image

Zanamivir Structural Formula (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 01)

Chemical structure diagram of the active ingredient associated with RELENZA, illustrating its molecular framework with hydroxyl groups, amino groups, and a carboxyl group. The structure shows the arrangement of carbon, oxygen, and nitrogen atoms in the molecule.*

FDA Label Image

Relenza Logo (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 02)

RELENZA (zanamivir) Inhalation Powder label with a blue background and yellow text. The label prominently displays the brand name RELENZA, the generic name zanamivir, and the dosage form as inhalation powder. The labeler is Physicians Total Care, Inc.*

FDA Label Image

Parts Of The Diskhaler (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 03)

Illustration showing parts of the RELENZA Diskhaler device labeled for identification. Components include the cover, white mouthpiece, dark brown wheel, white tray, raised ridges, needle, Diskhaler body, half-circle flap, and a silver medicine disk with four plisters. Each part is described with its functional role in the device operation.*

FDA Label Image

Step A: Steps 1, 2, 3, 4, 5, And 6 (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 04)

Instructional diagram showing six sequential steps to prepare and load a RELENZA inhaler device. Each step is illustrated with hands manipulating the inhaler, including removing and replacing a blue cap, pressing labeled areas marked with 'RIDGES' and 'PUSH,' revealing an internal circular blister, and readying the device for use. The RELENZA branding is visible on the inhaler.*

FDA Label Image

Step B: Steps 1, 2, 3, And 4 (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 05)

An instructional diagram showing four steps for using the RELENZA Diskhaler device. It illustrates holding the device level, inserting a medication blister, pressing to pierce the blister, and preparing the device for inhalation. The steps include a reminder to keep the Diskhaler level during use.*

FDA Label Image

Step C: Steps 1 And 2 (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 06)

Instructional illustration showing a woman using the RELENZA inhalation device. The first panel shows her holding the device away from her mouth preparing to inhale, and the second panel shows her inhaling from the device with the mouthpiece in her mouth.*

FDA Label Image

Step D: Steps 1 And 2 (Cf6c39b3 3e43 4e4d Bfe0 A0f6df088746 07)

Instructional diagram showing two steps to use the RELENZA inhaler device. The first image indicates sliding a part of the inhaler forward, and the second image shows pressing until a "CLICK" is heard, demonstrating how to load or activate the device for use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.